VFA 2009
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- HHSD200200930521I
- Awardee
-
Glaxosmithkline Holdings (Americas) Inc. UEI QQH9KHXNCG81
- Awarding agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- 2009N11276 Solicitation number
- CDC / NCIRD 2009 Adult Vaccine Contract Award Notice · Posted Apr 30, 2009
- Last date to order 100% complete
- IDV ceiling
- $809,252,070.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to Glaxosmithkline Holdings (Americas) Inc. The contract, identified as HHSD200200930521I, has a ceiling value of $809,252,070.00 and a period of performance from July 1, 2009 to June 30, 2010.
The contract, known as VFA 2009, does not have any set-asides and was awarded as a multiple-award vehicle. The purpose of the contract is to procure unspecified products and services, as detailed in the original solicitation. While the provided materials do not include specific task orders or price lists, the broad scope of the IDC suggests it may be used to support a variety of CDC initiatives and programs through the placement of individual task orders with the prime contractor, Glaxosmithkline Holdings (Americas) Inc.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$23,497 | |
| Supplemental Agreement for work within scope | $2,424,193 | |
| Supplemental Agreement for work within scope | $9,296,387 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $2,979,566 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $1,508,941 | |
| Supplemental Agreement for work within scope | $421,033 | |
| Supplemental Agreement for work within scope | $2,367,204 | |
| Supplemental Agreement for work within scope | $2,103,650 | |
| Supplemental Agreement for work within scope | $2,841,005 | |
| Supplemental Agreement for work within scope | $1,534,517 | |
| Supplemental Agreement for work within scope | $2,923,036 | |
| Supplemental Agreement for work within scope | $1,800,000 | |
| Original award | $1,000,000 |
Show all 17
Quick answers
Who was awarded contract HHSD200200930521I?
HHSD200200930521I was awarded to Glaxosmithkline Holdings (Americas) Inc. by CDC Office of Acquisition Services (Centers for Disease Control and Prevention) on July 1, 2009.
How much is contract HHSD200200930521I worth?
HHSD200200930521I's own ceiling is $809,252,070.
Who can order from contract HHSD200200930521I?
HHSD200200930521I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HHSD200200930521I competed?
The extent of competition for HHSD200200930521I was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV